Stay updated with breaking news from Jay Olson. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Biogen Inc. (NASDAQ: BIIB) shares fell Tuesday after it was deemed that the ability of the company's Alzheimer's drug, Leqembi, to slow cognitive decline may not outweigh its risks, according to European experts considering the potential use of it.
City finance officials report that its recent $1.56 billion general obligation bond sale was more than six times oversubcribed.
Olson, a 20-year municipal bond veteran, replaces Marjorie Henning who retired at the end of April. In his new position, he will be in charge of the Bureau of Public Finance, which manages the city's borrowing for the comptroller.
Pfizer's interest in acquiring Seagen stems from a need to recoup patent cliff revenue losses by replenishing its pipeline, analysts say.
The shortened week kicked off with one big crisis averted for now. During the long weekend, an agreement was reached between President Bide...